A detailed history of Shay Capital LLC transactions in Reneo Pharmaceuticals, Inc. stock. As of the latest transaction made, Shay Capital LLC holds 28,617 shares of RPHM stock, worth $48,076. This represents 0.01% of its overall portfolio holdings.

Number of Shares
28,617
Holding current value
$48,076
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.34 - $1.7 $38,346 - $48,648
28,617 New
28,617 $48,000

Others Institutions Holding RPHM

About Reneo Pharmaceuticals, Inc.


  • Ticker RPHM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,479,600
  • Market Cap $41.1M
  • Description
  • Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as w...
More about RPHM
Track This Portfolio

Track Shay Capital LLC Portfolio

Follow Shay Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shay Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shay Capital LLC with notifications on news.